Compare NGEN & ZSQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NGEN | ZSQR |
|---|---|---|
| Founded | 2017 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 200.0M | 204.6M |
| IPO Year | 2018 | 2020 |
| Metric | NGEN | ZSQR |
|---|---|---|
| Price | $2.18 | $3.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 605.4K | 307.1K |
| Earning Date | 04-02-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,363,045.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.58 | $2.81 |
| 52 Week High | $5.93 | $16.62 |
| Indicator | NGEN | ZSQR |
|---|---|---|
| Relative Strength Index (RSI) | 56.99 | 36.06 |
| Support Level | $1.62 | $2.81 |
| Resistance Level | $2.32 | $4.38 |
| Average True Range (ATR) | 0.16 | 0.46 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 63.60 | 20.16 |
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
Z Squared Inc is a computing infrastructure company operating computing equipment and expanding into AI infrastructure. The Company's idea is to build on three principles: guide with power by acquiring operating sites where power is already flowing; build for AI workloads by converting that capacity into AI-ready colocation where the customer brings the compute and runs what it needs; and scale with discipline by deploying conversion capital site by site, against signed contracts and operational readiness.